Alan I. Green

9.5k citations

100 papers · 7.0k indexed · 2 hit papers · h-index 42

Impact in

Psychiatry and Mental health top 0.2%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
Biological Psychiatry top 1%

Papers in

Psychiatry and Mental health 71
- Schizophrenia research and treatment 68
- Bipolar Disorder and Treatment 22
- Attention Deficit Hyperactivity Disorder 6
Cellular and Molecular Neuroscience 34
- Neurotransmitter Receptor Influence on Behavior 31

Co-authors: Joanne Wojcik Mary F. Brunette Larry J. Seidman Ming T. Tsuang Stephen V. Faraone Susan Whitfield‐Gabrieli James Reich Robert W. McCarley
Journals: Schizophrenia Research (11 papers)Psychiatry Research (5 papers)American Journal of Psychiatry (5 papers)The Journal of Clinical Psychiatry (5 papers)Psychiatric Services (4 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Alan I. Green

98 papers receiving 6.7k citations

Hit Papers

align trajectories log scale

Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia 2009 · 1.2k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2009 Proceedings of the National Academy of Sciences
1996 Psychiatric Services

Peers

Countries citing papers authored by Alan I. Green

Since Specialization

Citations

This map shows the geographic impact of Alan I. Green's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan I. Green with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan I. Green more than expected).

Fields of papers citing papers by Alan I. Green

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan I. Green. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan I. Green. The network helps show where Alan I. Green may publish in the future.

Co-authors

The 25 scholars most cited alongside Alan I. Green, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alan I. Green Line = papers co-authored together Alan I. Green links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Glutamine and GABA alterations in cingulate cortex may underlie alcohol drinking in a rat model of co-occurring alcohol use disorder and schizophrenia: an 1H-MRS study Schizophrenia ·Yu-Fai, Xi Chen, Barjor Gimi, Alan I. Green, Jibran Y. Khokhar	2022	4
2	Building capacity for collaborative research on opioid and other substance use disorders through the Clinical and Translational Science Award Program SHILAP Revista de lepidopterología ·Linda B. Cottler, Alan I. Green, Harold Alan Pincus, Scott McIntosh, Jennifer Humensky, Kathleen T. Brady	2019	9
3	Unique Effects of Clozapine: A Pharmacological Perspective Advances in pharmacology ·Jibran Y. Khokhar, Angela M. Henricks, Jiang He-fu, Alan I. Green	2018	133
4	An open-label pilot study of quetiapine plus mirtazapine for heavy drinkers with alcohol use disorder Alcohol ·Mary F. Brunette, Sarah Akerman, Ree Dawson, Christopher O’Keefe, Alan I. Green	2016	10
5	Desipramine enhances the ability of risperidone to decrease alcohol intake in the Syrian golden hamster Psychiatry Research ·Danielle Gulick, David T. Chau, Jibran Y. Khokhar, Ree Dawson, Alan I. Green	2014	8
6	Schizophrenia and co-occurring substance use disorder: Reward, olfaction and clozapine Schizophrenia Research ·Raquelle I. Mesholam‐Gately, Lauren E. Gibson, Larry J. Seidman, Alan I. Green	2014	18
7	Pharmacotherapy of Co-Occurring Schizophrenia and Substance Use Disorders Current Addiction Reports ·Sarah Akerman, Mary F. Brunette, Douglas L. Noordsy, Alan I. Green	2014	12
8	Deep brain stimulation of the nucleus accumbens reduces alcohol intake in alcohol-preferring rats Neurosurgical FOCUS ·Muhammad Zidan Kurniawan, Alan I. Green, Dominique Rousseau, David T. Chau, David W. Roberts, James C. Leiter	2010	91
9	Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia Proceedings of the National Academy of Sciences ·Susan Whitfield‐Gabrieli, Heidi W. Thermenos, Snežana Milanović, Ming T. Tsuang, Stephen V. Faraone, Robert W. McCarley, Martha E. Shenton, Alan I. Green, Alfonso Nieto-Castañón, Peter S. LaViolette, Joanne Wojcik, John D. E. Gabrieli, Larry J. Seidman Hit paper breakdown →	2009	1158
10	Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode Schizophrenia Research ·Diana O. Perkins, Jacqueline L. Johnson, Robert M. Hamer, Robert B. Zipursky, Richard S.E. Keefe, Natsuki Atagi, Alan I. Green, Ira Glick, René S. Kahn, Tonmoy Sharma	2006	139
11	Improving the Care of Individuals with Schizophrenia and Substance Use Disorders: Consensus Recommendations Journal of Psychiatric Practice ·Douglas Ziedonis, David Smelson, Richard N. Rosenthal, Steven L. Batki, Alan I. Green, T. Anitha, Iván D. Montoya, Joseph Parks, Roger D. Weiss	2005	137
12	Quality of life during treatment with haloperidol or olanzapine in the year following a first psychotic episode Schizophrenia Research ·Stephen M. Strakowski, Jacqueline L. Johnson, Melissa P. DelBello, Robert M. Hamer, Alan I. Green, Mauricio Tohen, Jeffrey A. Lieberman, Ira D. Glick, Jayendra K. Patel	2005	18
13	Effects of pharmacological doses of 2-deoxyglucose on plasma catecholamines and glucose levels in patients with schizophrenia Psychopharmacology ·Igor Elman, David Rott, Alan I. Green, Daniel D. Langleben, Scott E. Lukas, David S. Goldstein, Alan Breier	2004	11
14	Comparative Efficacy and Safety of Atypical and Conventional Antipsychotic Drugs in First-Episode Psychosis: A Randomized, Double-Blind Trial of Olanzapine Versus Haloperidol American Journal of Psychiatry ·Jeffrey A. Lieberman, Gary D. Tollefson, Mauricio Tohen, Alan I. Green, Raquel E. Gur, René S. Kahn, Joseph P. McEvoy, Diana O. Perkins, Tonmoy Sharma, Robert B. Zipursky, John Michael Suffredini, Robert M. Hamer, (unknown)	2003	322
15	Detection and management of comorbidity in patients with schizophrenia Psychiatric Clinics of North America ·Alan I. Green, Carla M. Canuso, Mark Brenner, Joanne Wojcik	2003	116
16	Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder Psychiatry Research ·Carla M. Canuso, Jill M. Goldstein, Joanne Wojcik, Ree Dawson, Danielle Brandman, Anne Klibanski, Joseph J. Schildkraut, Alan I. Green	2002	73
17	Concurrent validation of schizotaxia: a pilot study Biological Psychiatry ·William S. Stone, Stephen V. Faraone, Larry J. Seidman, Alan I. Green, Joanne Wojcik, Ming T. Tsuang	2001	21
18	Treatment of nonpsychotic relatives of patients with schizophrenia: four case studies Biological Psychiatry ·Ming T. Tsuang, William S. Stone, Larry J. Seidman, Stephen V. Faraone, Ruben III Arvizu, Joanne Wojcik, J. Paul Kelleher, Alan I. Green	1999	61
19	Clozapine for Comorbid Substance Use Disorder and Schizophrenia: Do Patients with Schizophrenia Have a Reward-Deficiency Syndrome That Can Be Ameliorated by Clozapine? Harvard Review of Psychiatry ·Alan I. Green, Ruben III Arvizu, 健二朗白沢, Joseph J. Schildkraut	1999	133
20	Clozapine response and plasma catecholamines and their metabolites Psychiatry Research ·Alan I. Green, ฐิติรัตน์ เหลืองลออ, Sumaya Eljabri, 悟橘, Christine Waternaux, Carl Salzman, Alan F. Schatzberg, Joseph J. Schildkraut	1993	63

About Alan I. Green

Alan I. Green is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience, Pharmacology, Clinical Psychology and Cognitive Neuroscience, having authored 100 papers that have together received 7.0k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (68 papers), Neurotransmitter Receptor Influence on Behavior (31 papers), Bipolar Disorder and Treatment (22 papers), Substance Abuse Treatment and Outcomes (11 papers), Obsessive-Compulsive Spectrum Disorders (9 papers), Diet and metabolism studies (7 papers), Attention Deficit Hyperactivity Disorder (6 papers) and Cannabis and Cannabinoid Research (6 papers). The work is most often cited by research in Psychiatry and Mental health (3.4k citations), Biological Psychiatry (381 citations), Cognitive Neuroscience (1.8k citations), Cellular and Molecular Neuroscience (1.5k citations) and Clinical Psychology (1.5k citations). Alan I. Green has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Joanne Wojcik, Mary F. Brunette, Larry J. Seidman, Ming T. Tsuang, Stephen V. Faraone, Susan Whitfield‐Gabrieli, James Reich, Robert W. McCarley, Martha E. Shenton and Douglas L. Noordsy. Their work appears in journals such as Schizophrenia Research, Psychiatry Research, American Journal of Psychiatry, The Journal of Clinical Psychiatry and Psychiatric Services.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact